NCT05542966View on ClinicalTrials.gov

Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury

Active, not recruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

August 3, 2023

Study Completion Date

December 31, 2023

Conditions

Cardiac FailureCritical Illness

Trial Locations (1)

3004

Alfred Hospital, Melbourne

All Listed Sponsors

lead

Australian and New Zealand Intensive Care Research Centre

OTHER